Blocking the RhoA/ROCK/cofilin/F-actin Pathway via Y27632 Protects Against MERTK-deficient Retinal Degeneration and

Lujia Feng1, Ting Zhang2, Yong Du1

  • 1Shenzhen Eye Hospital, Shenzhen Eye Center, Southern Medical University, Shenzhen, 518040, China.

Abstract

Insights

Mer receptor tyrosine kinase (MERTK) deficiency impairs retinal pigment epithelium (RPE) function and survival, leading to vision loss in retinitis pigmentosa (RP). Targeting the RhoA/ROCK pathway can restore RPE phagocytosis and cell survival.

Area of Science:

  • Ophthalmology
  • Genetics
  • Cell Biology

Background:

  • Retinitis pigmentosa (RP) is a common inherited neurodegenerative retinal disease.
  • Mutations in Mer receptor tyrosine kinase (MERTK) are linked to severe RP and retinal pigment epithelium (RPE) dysfunction.
  • The Rho-associated coiled-coil-containing kinases (ROCK) pathway's role in MERTK-associated RP requires elucidation.

Purpose of the Study:

  • To investigate the role of the RhoA/ROCK pathway in MERTK-associated retinal pigment epithelium (RPE) dysfunction.
  • To explore potential therapeutic targets for retinitis pigmentosa (RP) by understanding MERTK's regulatory mechanisms.

Main Methods:

  • Established an in vitro model of RP using MERTK-depleted human primary RPE (HsRPE) cells.
  • Utilized RCS rats with spontaneous Mertk mutations as an in vivo animal model.
  • Assessed cell viability, apoptosis, phagocytosis, and visual function using various assays and microscopy; quantified gene and protein expression.

Main Results:

  • MERTK knockdown in HsRPE cells reduced cell survival, increased apoptosis, and impaired phagocytosis.
  • Mertk mutations in rats similarly affected RPE phagocytosis, apoptosis, and visual function.
  • MERTK deficiency upregulated RhoA/ROCK/cofilin phosphorylation and decreased F-actin; ROCK inhibition rescued MERTK depletion-induced defects.

Conclusions:

  • MERTK is crucial for maintaining RPE survival and phagocytosis through the RhoA/ROCK/cofilin/F-actin pathway.
  • MERTK deficiency contributes to RP pathogenesis by impairing RPE function and promoting apoptosis.
  • These findings offer insights into RP and potential avenues for future drug development.